Can remission be in juvenile idiopathic arthritis without the use of biological agents?
Objective: to evaluate the efficiency and safety of therapy with subcutaneous (SC) methotrexate (MTX) in patients with juvenile idiopathic arthritis (JIA) without systemic manifestations.Patients and methods. The paper presents the results of a prospective study of the efficacy and safety of MTX in...
Saved in:
| Main Authors: | S. I. Valieva, A. A. Glazyrina, N. N. Kuleshov, M. S. Dzis, S. Kh. Kurbanova, A. S. Sologub, E. A. Korobiyants, V. T. Yusupova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2019-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/932 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical remission rate and drug withdrawal status in articular juvenile idiopathic arthritis
by: Akira Oshima, et al.
Published: (2025-02-01) -
Methotrexate in the combination therapy of juvenile idiopathic arthritis
by: E. S. Zholobova, et al.
Published: (2018-09-01) -
Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center
by: Mustafa Çakan, et al.
Published: (2017-10-01) -
RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF HYPODERMIC METHOTREXATE INJECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01) -
POSSIBLE PARENTERAL METHOTREXATE APPLICATION IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Yu. М. Spivakovsky, et al.
Published: (2014-12-01)